28 Feb Evoco has acquired leading med tech company, as part of Austrian portfolio transaction
Zurich, 23 February 2022
Evoco is pleased to announce that Evoco TSE III has acquired 100 % of the Agency for Medical
Innovations (A.M.I., www.ami.at) from aws Mittelstandsfonds and other shareholders.
A.M.I., headquartered in Feldkirch, is an Austrian manufacturer of high-quality medical
technology and products. The Company was founded in 1998 and employs over 125 people
in Austria and several international sales subsidiaries. A.M.I. seeks to improve the quality of
patient care by developing innovative products and treatment methods for surgical
application. The company’s product portfolio is centred around the core disciplines of
urology, urogynaecology and coloproctology, significantly contributing to patients’ quality of
life, through minimally invasive medical procedures.
Evoco will support A.M.I.’s plans for next level growth and closely collaborate with the existing
management team to capitalise on untapped value creation potential. The Company will be
able to leverage the Evoco toolkit, particularly in the areas of governance and distribution
Michel Galeazzi, Partner & Co-Founder of Evoco, commented, “We are excited to collaborate
with A.M.I. and take an active role in the development and future success of the Company.
We are impressed with A.M.I.’s outstanding reputation and high-quality products in
specialised markets, expected to benefit from long term demographic trends.”
Lorenzo Sormani, Director at Evoco, added, “This transaction is an excellent demonstration
of Evoco’s strategy of investing in resilient companies, operating in attractive segments, with
the potential to deliver on untapped growth and value.”
Nina Dohrau and Christoph Haimberger, Management Board of aws Mittelstandsfonds,
commented, “We are pleased the transaction has been completed successfully and believe
that Evoco represents a strong equity partner for the portfolio companies. Evoco not only
supports further growth of the companies, it also elevates our national investments to a
European level, strengthening Austrian’s position as an attractive business region.”
As part of the transaction Evoco will also acquire stakes in two additional companies,
Document.One (www.document.one) and Communi5 (www.communi5.com).
Document.One, headquartered in Vienna, is active in Enterprise Content Management (ECM).
Communi5, also headquartered in Vienna, is a software manufacturer of communications
solutions for service providers. We are pleased to partner with Document.One and Communi5
and look forward to working closely on their continued growth.
Schindler Attorneys, Medows and Grant Thornton advised the Evoco team on the transaction.
On the sell side, WMWP and Clairfield advised aws Mittelstandsfonds on the transaction.
Evoco AG is a lower mid-market manager based in Zurich, investing in growth and buyout
investments in Western Europe, with a focus on the DACH region. Since 2012, Evoco has
invested in 25 companies. This is the second portfolio investment for Evoco TSE III, which held
its final close in December 2021.
About aws Mittelstandsfonds
aws Mittelstandsfonds is a growth equity fund based in Vienna, offering equity and mezzanine
capital investments for Austrian small and medium sized enterprises. So far, together with coinvestors, around EUR 160 million have been invested in more than 20 portfolio companies,
including several successful exits. aws Mittelstandsfonds is a 100% subsidiary of Austria